news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Beijing News (Reporter Wang Ziyang) On July 31, Danone released its 2024 semi-annual report showing that sales revenue in the first half of the year was 13.757 billion euros, a year-on-year increase of approximately 4%, of which sales volume and mix contributed approximately 2.1% of the growth, and all categories achieved growth.

According to the financial report, Danone's sales revenue in the second quarter of 2024 was 6.938 billion euros, a year-on-year increase of about 4%, of which sales and mix contributed about 2.9% of the growth, and price factors drove about 1% of the growth. As a result, sales revenue in the first half of the year reached 13.757 billion euros, a year-on-year increase of about 4%, of which sales and mix contributed about 2.1% of the growth, and price factors drove about 2% of the growth.

In the first half of the year, sales revenue in China, North Asia and Oceania reached 1.841 billion euros, up 8.6% year-on-year. Other regions also saw growth to varying degrees. Sales revenue in Europe reached 4.783 billion euros, up 1.7% year-on-year; sales revenue in North America reached 3.331 billion euros, up 3.7% year-on-year; sales revenue in Latin America reached 1.556 billion euros, up 4.6% year-on-year; and sales revenue in other regions of the world reached 2.246 billion euros, up 5.6% year-on-year.

By business, the professional special nutrition business had sales revenue of 4.414 billion euros in the first half of the year, a year-on-year increase of 4.3%; the drinking water and beverage business had sales revenue of 2.557 billion euros, a year-on-year increase of 6%; and the basic dairy and plant-based business had sales revenue of 6.785 billion euros, a year-on-year increase of 3.1%.

In the Chinese market, Danone achieved sales revenue of 1.001 billion euros in China, North Asia and Oceania in the second quarter, an increase of 8.4% year-on-year, of which sales volume and mix contributed 9.4% growth, while price factors led to a 1% decline. In the Chinese market, the two major businesses of early life nutrition and medical nutrition continued to maintain competitive development momentum; Mizone achieved a strong start in the peak sales season.

Editor: Zhu Fenglan

Proofread by Lucy